Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization
- 19 March 2003
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 200 (5) , 577-588
- https://doi.org/10.1002/path.1371
Abstract
The accuracy and reliability of in situ studies may be compromised by qualitative interpretations. Quantitation imposes a greater degree of objectivity, is more reproducible, and facilitates the clarity of definitions. The aim of this study was to validate the utility of laser imaging systems for the in situ quantitative analysis of gene expression in tissue microarrays. Immunofluorescence was employed to quantify the expression of the tumour suppressor p53, a marker of proliferation (Ki67), an endothelial cell marker (CD31), and the mismatch repair proteins human Mut L homologue 1 and human Mut S homologue 2 in an arrayed series of colorectal tissues (n = 110). Quantitative data on this panel of antigens were compared objectively with qualitative scoring of immunohistochemical chromogen deposition. In addition, the expression of vascular endothelial growth factor (VEGF)‐A, placental growth factor, hepatocyte growth factor, and c‐Met mRNA was quantified by phosphor image analysis of in situ hybridization reactions. The quantified data on p53, Ki67, and CD31 expression were significantly associated with the pathologist's score (p ≤ 0.001). While hepatocyte growth factor and placental growth factor were not up‐regulated, c‐Met expression was increased up to 2.5‐fold and the median VEGF‐A expression was elevated 4‐fold (p = 0.003) in this series of colorectal tumours. Laser imaging systems are therefore feasible for high‐throughput, quantitative profiling of tissue microarrays. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 46 references indexed in Scilit:
- Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studiesThe Journal of Pathology, 2001
- Vascular endothelial growth factor (VEGF) – a valuable serum tumour marker in patients with colorectal cancer?European Journal of Surgical Oncology, 2001
- Vegf, vegf-B, vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosaInternational Journal of Cancer, 2000
- Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinomaCancer, 2000
- Vascular Endothelial Growth Factor in Human Colon Cancer: Biology and Therapeutic ImplicationsThe Oncologist, 2000
- Quantitative Analysis of Vascular Endothelial Growth Factor in Colon CancerEuropean Surgical Research, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasisInternational Journal of Cancer, 1997
- Standardization and quality control of quantitative microscopy in pathologyJournal of Cellular Biochemistry, 1993
- Agarose beads as matrices for proteins in cytophotometric investigations of immunohistoperoxidase procedures;.Journal of Histochemistry & Cytochemistry, 1975